Targeting the Tumor Microenvironment

JOURNAL ARTICLE

Year: 2009 Journal: Science Translational Medicine Vol: 1 (6) Publisher: American Association for the Advancement of Science

DOI: 10.1126/scitranslmed.3000560

Abstract

A Stat3 -stifling siRNA augmented with an oligonucleotide agonist of a Toll-like receptor stimulates tumor-destroying immune responses.

Keywords:

Tumor microenvironment Cancer research Medicine Computational biology Biology Tumor cells

Cited By

0.00

FWCI (Field Weighted Citation Impact)

Refs

0.16

Citation Normalized Percentile

Is in top 1%

Is in top 10%

Immune Response and Inflammation

Life Sciences → Immunology and Microbiology → Immunology

Cancer Research and Treatments

Life Sciences → Biochemistry, Genetics and Molecular Biology → Biotechnology

Immunotherapy and Immune Responses

Life Sciences → Immunology and Microbiology → Immunology